Cosmetic surgery centers provide elective surgical and non-surgical aesthetic procedures including rhinoplasty, breast augmentation, liposuction, facelifts, injectables, and laser treatments. The industry operates at the intersection of healthcare and consumer discretionary spending, with demand driven by aging demographics, social media influence, and growing acceptance of aesthetic enhancement. Lower middle market centers typically serve local markets with a mix of high-margin surgical cases and high-volume non-surgical repeat treatments.
Who buys these: Private equity groups focused on healthcare services, strategic acquirers such as regional or national med-spa and cosmetic surgery chains, high-net-worth individual investors with medical or business backgrounds, and physician entrepreneurs looking to expand their practice footprint
3.5–6×
Typical EBITDA multiple
$1M–$5M
Revenue range
Growing
Market trend
SBA Eligible
7(a) financing available
Typically targets centers with $1M–$5M in revenue, EBITDA margins of 15–30%, a diversified procedure mix, minimal physician key-man dependency, clean malpractice history, and stable or growing patient volume over 3+ years. SBA financing preferred for smaller deals; PE platforms often require $2M+ EBITDA for add-ons.
Get Deal Flow In Your Inbox
New Cosmetic Surgery Center acquisition targets delivered weekly — free to join.
Key items to investigate when evaluating a Cosmetic Surgery Center acquisition
Seller Intelligence
Who sells Cosmetic Surgery Center businesses?
Plastic surgeons, facial surgeons, and dermatologic surgeons nearing retirement (ages 55–70), physician partners seeking liquidity events, founders looking to transition to a clinical-only role, and multi-location aesthetic practice owners pursuing a strategic exit
Typical exit timeline: 12–24 months
Cosmetic Surgery Center businesses in the $1M–$5M revenue range typically sell for 3.5–6× EBITDA. Typically targets centers with $1M–$5M in revenue, EBITDA margins of 15–30%, a diversified procedure mix, minimal physician key-man dependency, clean malpractice history, and stable or growing patient volume over 3+ years. SBA financing preferred for smaller deals; PE platforms often require $2M+ EBITDA for add-ons.
Cosmetic Surgery Center businesses typically trade at 3.5–6× EBITDA in the lower middle market. The market is highly fragmented with growing demand, which supports premium multiples.
Cosmetic Surgery Center businesses are SBA 7(a) eligible, making them accessible to first-time buyers. Asset purchase with an MSO structure to comply with CPOM regulations, separating the medical PC from the business entity
Key due diligence areas include: Corporate practice of medicine compliance and management services organization (MSO) structure review; Malpractice claims history, pending litigation, and adequacy of tail coverage; Physician and key staff employment agreements, non-competes, and retention likelihood post-sale; Patient volume trends, procedure mix concentration, and revenue sustainability without the selling physician; Licensing, accreditation (AAAHC, Joint Commission), DEA registrations, and facility certifications.
Related Searches
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — all in one place.
Start finding deals — freeNo credit card required
For Buyers
For Sellers